|
Match
|
Document |
Document Title |
|
|
5852003 |
Drug and pharmaceutical composition for the treatment of muscles
Use of at least one polymer or one biopolymer, called HBGFPP, specifically protecting the growth factors of the FGF and beta TGF families from tryptic degradation in the manufacture of a drug for...
|
|
|
5847112 |
Process for making capsular polysaccharides from Streptococcus pneumoniae
Type-specific capsular polysaccharide preparations from Streptococcus pneumoniae, having on average less than about 1000 oligosaccharide repeat units per molecule, polydispersities between 1.0 and...
|
|
|
5846788 |
Process for preparing a lignocellulose-based product, and product obtainable by the process
A process for the manufacture of a lignocellulose-based product from a lignocellulosic material comprises treating the lignocellulosic material and a phenolic polysaccharide having substituents...
|
|
|
5847110 |
Method of reducing a schiff base
The invention relates to methods of reducing Schiff bases and making chelator conjugates by treating with borane-pyridine complex.
|
|
|
5847109 |
Galactomannan products and compositions containing the same
An isolated galactomannan having at least 50 repeating units of mannose and galactose in a ration of between 0.5-1.0 and 1.8-1.0, and having a protein content of less than 20 wt. %, a saponin...
|
|
|
5844103 |
Anionic glycasuccinamide sufactants and a process for their manufacture
The present invention relates to a new class of carbohydrate based nonionic surfactant, i.e., alkyl and alkenyl glycasuccinamide, and a process for their manufacture.
|
|
|
5840884 |
Method for controlling crystal morphology of inulin
A method for controlling and/or modifying the morphology of inulin is provided. Using this method, inulin can be produced having, as desired, a predominately needle-like morphology or a...
|
|
|
5834423 |
Pharmaceutical composition containing sialic acid derivatives
The present invention is a pharmaceutical composition used as an antiviral agent, a diarrheal remedy, an antiulcer agent, an anti-inflammatory agent, an anti-allergic agent and an agent for...
|
|
|
5833883 |
Cross-linked biobased materials and uses thereof
Biobased cross-linked compositions, methods of fabrication and structures, in particular biobased printed wiring boards using the compositions and methods of making the structures are described....
|
|
|
5831044 |
Process for preparation of glycosides
A process for making glycosides having enhance color properties comprising the steps of: (a) reacting a reducing saccharide with excess fatty alcohol to obtain a glycoside reaction mixture; (b)...
|
|
|
5831082 |
Process for obtaining, by separation, highly pure water-soluble polydextrose
A process for obtaining, by separation, highly pure, water soluble polydextrose using a continuous simulated moving bed system. The process involves separation from a crude polydextrose mixture...
|
|
|
5831081 |
Process for the purification of water-soluble cyclodextrin derivatives
A process for the purification of water-soluble cyclodextrin derivatives utilizes a reverse osmosis (RO) using at least one hydrophilic, asymmetric solution-diffusion membrane with a nominal...
|
|
|
5827937 |
Polysaccharide gel composition
The present invention provides a process for preparing a cross-linked biocompatible polysaccharide gel composition, which comprises: forming an aqueous solution of a water soluble,...
|
|
|
5827697 |
Process for preparing glucans having a cyclic structure
The present invention provides glucans and derivatives thereof which are useful as raw materials in the starch processing industries, food and drink compositions, food additive compositions, and...
|
|
|
5824659 |
Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
The present invention relates to a glucose-rich, mannose-containing oligosaccharide described herein has a molecular weight of approximately 1,000-5,000 daltons and is separated from interfering...
|
|
|
5824797 |
Guar as a deposition and bioefficacy aid
Aerial spray or discharge drift is reduced, deposition improved and bioefficacy enhanced in aqueous compositions via the use of selected non-visco-elastic amounts of guar, one or more derivatives...
|
|
|
5817643 |
Underivatized, aqueous soluable β(1-3) glucan, composition and method of making same
The present invention relates to neutral, aqueous soluble β-glucans which exert potent and specific immunological effects without stimulating the production of certain cytokines, to preparations...
|
|
|
5817634 |
Methods of treating diabetes mellitus and clycogen storage disease
This present invention provides a method and compounds for priming the incorporation of cellular glucose into an oligosaccharide in a cell comprising administering to the cell a priming amount of a...
|
|
|
5814621 |
Drug composition and process for preparing the same
A drug composition comprising a mucopolysaccharide (also referred in the art as a glycosaminoglycan) and a drug which is scarcely soluble in water but soluble in a water-miscible organic solvent,...
|
|
|
5811532 |
Covalently bound, polysaccharide-based chiral stationary phases
There are described stable, non-leaching chiral stationary phases in which a chiral polysaccharide or polysaccharide derivative is covalently bound through a spacer to the surface hydroxyl groups...
|
|
|
5801240 |
Method for extracting semi-refined carrageenan from seaweed
An improved method of producing semi-refined kappa carrageenan is provided having processing steps including: (a) pre-rinsing carrageenan containing seaweed; (b) cooking the seaweed in a cooking...
|
|
|
5801238 |
Method for producing water absorbent resin and water absorbent
A method for producing a water absorbent resin comprising the step of radically polymerizing a water-soluble radically polymerizable monomer having an acid group or a group of the salt thereof and...
|
|
|
5798343 |
7-O-Carbamoylheptose derivatives, process for their production and their use in treating pseudomonas infections
The invention describes 7-O-carbamoyl heptose derivatives of general formula (I) in which R is the substituent R 1 or a group of general formula (II) in which R 1 is a hydrogen atom, a methyl...
|
|
|
5792753 |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
A topically administrable pharmaceutical composition is disclosed which comprises a therapeutically effective amount of a drug which inhibits prostaglandin synthesis, and an amount of a form of...
|
|
|
5792842 |
Ganglioside GM3 derivative having fluorine atom at 9-position of sialic acid and intermediates therefor
A ganglioside GM3 derivative having a fluorine atom at the 9-position of sialic acid represented by the formula: ##STR1## wherein R is an aliphatic lower acyl group, R 1 is a hydrogen atom or a...
|
|
|
5789392 |
Saccharide composition with reduced reducibility, and preparation and uses thereof
A saccharide composition with a reduced reducibility which is prepared by hydrogenating a saccharide mixture comprising reducing saccharides and non-reducing saccharides consisting of trehalose...
|
|
|
5785975 |
Adjuvant compositions and vaccine formulations comprising same
The present invention relates to phospholipid-polysaccharide adjuvant compositions and to vaccine formulations comprising same, as well as to methods of making and using such adjuvants and vaccines.
|
|
|
5786342 |
Uses of aloe products in the treatment of chronic respiratory diseases
Acemannan has been shown to be effective in treating a number of conditions where the principal mechanism of resolution or cure requires intervention by the patient's immune system. Acemannan has...
|
|
|
5783569 |
Uses for underivatized, aqueous soluble β(1-3) glucan and compositions comprising same
The present invention relates to neutral, aqueous soluble β-glucans which exert potent and specific immunological effects without stimulating the production of certain cytokines, to preparations...
|
|
|
5783568 |
Methods for treating cancer and other cell proliferative diseases
The present invention relates to a method of treating in a mammal certain cancers, other cell proliferative diseases, and/or angiogenesis by using a salt or complex of a sulfated saccharide. The...
|
|
|
5783692 |
Alkyl polysaccharide derivatives and compositions
This invention relates to novel alkylpolysaccharide dertivatives including their salts and compositions comprising said alkyl polysaccharides. The alkyl polysaccharide derivatives are of the...
|
|
|
5780453 |
Uses of aloe products in the treatment of multiple sclerosis
Method for reducing symptoms associated with multiple sclerosis in an animal by administering to the animal an effective amount of an acetylated polymeric mannan derivative.
|
|
|
5780442 |
Orthosomycins from micromonospora carbonacae
Orthosomycins have been isolated from the fermentation broth of the microorganism Micromonospora Carbonacea var Africana designated SCC 2146. These compounds are antibacterial agents. Compositions...
|
|
|
5780620 |
Non-reducing oligosaccharides and their production and use
Novel non-reducing oligosaccharide having a structure represented by the formula of alpha-D-oligoglucosyl alpha-D-oligoglucoside is obtained by exposing either an aqueous solution which contains...
|
|
|
5780619 |
Starch graft poly(meth)acrylate blast media
The invention discloses a starch graft poly(meth)acrylate blast media which is effective in paint removal. The media is superior to a physical blend of the components (i.e., starch and acrylic...
|
|
|
5777090 |
Carboxymethyl inulin
Disclosed is carboxymethyl inulin having a degree of substitution (DS) ranging from 0,15 to 2,5, preferably from 0,5 to 1,5, a process for the preparation of said carboxymethyl inulin by reacting...
|
|
|
5776912 |
Lipophilic oligosaccharide antibiotic compositions
An aqueous pharmaceutical composition comprising a lipophilic oligosaccharide antibiotic salt, e.g., the N-methylglucamine salt of the everninomicin-type antibiotic of Formula III together with a...
|
|
|
5777102 |
Carrageenan-containing product and a method of producing same
A method of producing a carrageenan-containing product comprising reacting a carrageenan-containing seaweed starting material in a substantially homogenous mixture of a solvent in which carrageenan...
|
|
|
5773608 |
Process for preparing stabilized chitin derivative compounds
A process for sterilizing a polysaccharide composition containing chitosan, a chitosan derivative or a chitin derivative without substantially degrading the polysaccharide. The process has the...
|
|
|
5773426 |
Proteoglucan and antidiabetic drug thereof
This Invention is to provide a proteoglucan and an antidiabetes drug containing the proteoglucan, as an active ingredient, which possess an excellent effect against non-insulin dependent diabetes...
|
|
|
5772646 |
Absorbent structure comprising a microbial polysaccharide and a process of making the same
Disclosed is an absorbent structure comprising a microbial polysaccharide having improved porosity and a process of making the same. The absorbent structure may be adapted for use in an absorbent...
|
|
|
5773604 |
Polyol composition, process for its preparation and its applications
The invention relates to a polyol composition exhibiting a very high heat stability and a very high chemical stability, characterized in that it exhibits an optical density lower than or equal to...
|
|
|
5773595 |
Cationic sugar surfactants
A cationic sugar surfactant made by a process involving: (a) reacting an alkyl or alkenyl oligoglycoside of the formula (I): R 1 O-- G! p (I) wherein R 1 ...
|
|
|
5770208 |
Staphylococcus aureus B-linked hexosamine antigen
A negatively-charged S. aureus antigen contains β-hexosamine as a major carbohydrate component. S. aureus strains that carry the antigen account for nearly all of the clinically significant...
|
|
|
5770711 |
Polysaccharides substituted with polycarboxylated moieties
A derivatized polysaccharide in which at least a portion of the active hydrogens originally present in the polysaccharide are substituted by monovalent aliphatic groups containing at least two...
|
|
|
5767107 |
Compositions containing gluten and polysaccharides that contain uronic acid residues useful for encapsulating fats, oils and solids
The present invention relates to compositions useful for encapsulating fats, oils or solids, comprising gluten and polysaccharides that contains uronic acid residues.
|
|
|
5767255 |
Glucose- and sophorose-lipids, a process for their preparation and their use
The present invention relates to glucose- and sophorose-lipids of the formula I ##STR1## in which R 4 is --OH or a group of the formula II, ##STR2## n is an integer from 2 to 26, R 1 and R 2 ...
|
|
|
5763413 |
Lewis-associated compound, process for producing the same, and anti-inflammatory
A Lewis-associated compound, represented by general formula (I), a process for producing the same, and an anti-inflammatory, wherein R 1 and R 3 represent each hydrogen, m SO 3 H or CH 2 COOH;...
|
|
|
5763427 |
Compositions and methods for inhibiting thrombogenesis
The present invention provides compositions and methods for inactivating thrombin bound to fibrin within a thrombus or clot, whereby the ability of clot-bound thrombin to catalytically promote...
|
|
|
5763600 |
Oligosaccharide antibiotics and process for preparation thereof
Novel oligosaccharide antibiotics of formula I and I' are disclosed, together with a method for their preparation.
|